Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 3:45 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 529–552 of 668 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: University of Illinois Chicago Clear all

Conditions: Ocular Graft vs Host Disease, Dry Eye
Interventions: rhDNase I, Vehicle; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Pancreatic Cancer, Pancreatic Adenocarcinoma, Duodenal Cancer, Distal Cholangiocarcinoma
Interventions: Hydrocortisone, Pancreatic resection; Drug · Procedure
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Overweight and Obesity
Interventions: Not listed
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 60 Years
Enrollment: 139 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Malocclusion, Misaligned Teeth
Interventions: Clear Aligners with Dental Monitoring, Clear Aligners; Device
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 12 Years to 70 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2029
U.S. locations: 4
States / cities: Antioch, Illinois • Chicago, Illinois • Grayslake, Illinois + 1 more

Conditions: Hot Flashes, Hot Flushes, Vasomotor Symptoms
Interventions: Stellate Ganglion Block injection with bupivicaine, Saline; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 30 Years to 70 Years · Female only
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Sickle Cell Disease
Interventions: Haploidentical Transplant, Alemtuzumab, Total Body Irradiation, Cyclophosphamide, Sirolimus; Procedure · Drug · Radiation
Lead sponsor: Damiano Rondelli, MD; Other
Eligibility: 16 Years to 60 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Visual Function
Interventions: Izon Wavefront-guided lenses, Conventional lenses; Device
Lead sponsor: The Chicago Lighthouse; Other
Eligibility: 18 Years to 35 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Intraepithelial Prostatic Neoplasia, Prostatic Neoplasms
Interventions: Lycopene 30mg, Placebo; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 40 Years and older · Male only
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Chronic Stroke
Interventions: Neuromuscular electrical stimulation (NMES) or Functional electrical stimulation (FES); Device
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 90 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Healthy
Interventions: Hyperpolarized Xe129; Drug
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 25 Years to 35 Years
Enrollment: 260 participants
Timeline: 2023 – 2027
U.S. locations: 6
States / cities: Chicago, Illinois • Iowa City, Iowa • Kansas City, Kansas + 2 more

Conditions: Pregnancy Complications, Maternal Care Patterns, Patient Engagement
Interventions: Melanated Group Midwifery Care; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 15 Years to 49 Years · Female only
Enrollment: 432 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Motor Delay, Premature Birth, Intraventricular Hemorrhage, Hypoxic-Ischemic Encephalopathy, Bronchopulmonary Dysplasia
Interventions: Physical Therapy intervention; Other
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 33 Weeks to 48 Weeks
Enrollment: 222 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 3
States / cities: Chicago, Illinois

Conditions: COPD, Early-Onset
Interventions: Not listed
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 30 Years to 55 Years
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 14
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Los Angeles, California + 10 more

Conditions: Stroke
Interventions: Real Ischemic Conditioning, Sham Ischemic Conditioning; Device
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 21 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Primary Ovarian Insufficiency, Low Ovarian Reserve, Premature Ovarian Failure
Interventions: ROSE-1 Protocol; Procedure
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older · Female only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Brain Neoplasms
Interventions: HIVEN Medical Device; Device
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 99 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hypertension
Interventions: Walking (behavior); Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 25 Years to 59 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2004
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Knee Pain Chronic
Interventions: transcranial direct current stimulation, physical therapy; Device · Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Audio Processing Delay
Interventions: Audio delay; Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Bacterial Vaginosis, Vaginal Microbiome, Chlamydia Trachomatis Infection, Neisseria Gonorrheae Infection, Trichomonas Vaginitis
Interventions: Menstrual Cup; Device
Lead sponsor: Rush University Medical Center; Other
Eligibility: 15 Years to 35 Years · Female only
Enrollment: 408 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Breast Cancer Invasive, Early-stage Breast Cancer, High Risk Breast Carcinoma
Interventions: Azacitidine; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Sickle Cell Disease
Interventions: Exercise Test (CIIT); Other
Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago; Other
Eligibility: 10 Years to 21 Years
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 3
States / cities: Chicago, Illinois • Memphis, Tennessee

Conditions: Adverse Childhood Experiences, Family Functioning
Interventions: Garnering Resilience in Traumatized youth and families (GRIT), Digital Citizenship Curriculum (DCC); Behavioral
Lead sponsor: University of California, Irvine; Other
Eligibility: 11 Years to 14 Years
Enrollment: 210 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Irvine, California

Conditions: Colorectal Cancer Screening
Interventions: Community-Based (Intervention Arm); Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 45 Years to 74 Years
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 2
States / cities: Chicago, Illinois

Search by objective public record fields.

rhDNase Eye Drops in Patients With Ocular Graft-Vs.-Host Disease

GI-06: The Impact of Perioperative Hydrocortisone on Patients Undergoing Partial Pancreatectomy

Circadian Timing, Information Processing and Energy Balance Study

Optimizing Orthodontic Appliances Efficiency With Remote Dental Monitoring and Artificial Intelligence Algorithms

Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer

SCD-Haplo: Phase II Study of HLA-Haploidentical SCT for Aggressive SCD

Comprehensive Evaluation of Visual Function

The Effects of Lycopene on High Risk Prostatic Tissue

Effect of NMES on Balance and Fall Risk in Chronic Stroke

Hyperpolarized 129Xe MRI Lung Health Cohort

Melanated Group Midwifery Care (MGMC)

Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit

SPIROMICS Study of Early COPD Progression (SOURCE)

Motor and Neurophysiological Changes After Ischemic Conditioning in Individuals With Stroke

Rejuvenation of Premature Ovarian Failure With Stem Cells

Intraoperative Fluorescence-Guided Aspirate Tissue Monitoring of 5-ALA During Brain Tumor Surgery

Walking Intervention in African American Adults With Newly Diagnosed Hypertension

Transcranial Direct Current Stimulation in Conjunction With Individualized Physical Therapy for Individuals With Chronic Knee Pain

Effects of Delay in Hearing Assistive Technology

Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs

BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer

Sickle Cell Pro-Inflammatory Response to Interval Training Study

The THRIVE Study: Teaching Healthy Regulation in Individuals & Vulnerable Environments

Cancer Screening; Access; Awareness; Navigation